Clinically validated driver genes include the mutant oncoproteins BRAF (∼50% of melanomas), c-Kit (∼15%) and NRAS (∼20%) (Gray-Schopfer et al, 2007; Hodis et al, 2012). The gene discussed is BRAF; the disease is melanoma.